CD244 overexpression indicates NK cell dysfunction and tumor progression in diffuse large B-cell lymphoma

Area of Science:

• Immunology
• Oncology
• Cell Biology

Background:

• CD244 is implicated in natural killer (NK) and T cell dysfunction within the tumor microenvironment (TME).
• The specific role of CD244 in diffuse large B-cell lymphoma (DLBCL) and its underlying mechanisms are not well understood.

Purpose of the Study:

• To investigate the immunological significance of CD244 in DLBCL.
• To elucidate the regulatory mechanisms governing CD244 expression and function in DLBCL.

Main Methods:

• Single-cell and bulk RNA sequencing to analyze CD244 expression, adaptor molecules, and immune checkpoints.
• Immunohistochemistry and RT-qPCR to assess clinical and biological implications.
• Evaluation of intercellular communication, transcription factors, and somatic mutations.

Main Results:

• NK cells were the primary CD244-expressing population in DLBCL, co-expressing multiple inhibitory receptors.
• CD244 expression correlated with an immunosuppressive TME, poor clinicopathological features, and worse outcomes.
• Elevated CD244 was associated with potential responsiveness to immune checkpoint blockade (ICB) therapy.

Conclusions:

• CD244 plays a critical role in NK cell dysfunction and DLBCL progression.
• CD244 represents a potential therapeutic target for improving immunotherapy in DLBCL.